![](/img/cover-not-exists.png)
AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation
Ulrich Tebbe, Ralph Oeckinghaus, Karl-Friedrich Appel, Hubertus Heuer, Hendrik Haake, Egbert Eggers, Karlheinz Seidel, Jan Adams, Job HarenbergVolume:
97
Language:
english
Pages:
8
DOI:
10.1007/s00392-008-0644-y
Date:
June, 2008
File:
PDF, 267 KB
english, 2008